FIG 1.

Retrospective survival analysis of the first 11 patients receiving combination therapy with daptomycin plus ceftaroline (n = 11) at our hospital as part of a drug utilization evaluation compared to matched patients (1:2 ratio based on source of bacteremia, age, and renal function) receiving vancomycin monotherapy (n = 22). These were all pretrial patients. The P values for the difference in mortality at different times follow: after 30 days, P = 0.2; after 60 days, P = 0.14; after 1 year P = 0.06.